Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT02662868

Completed

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Metastatic Breast Cancer
NCT02947061

Unknown

S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer

Breast Cancer Recurrent
NCT01910844

Terminated

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes (META2)

Metastatic Breast Cancer
NCT00696072

Completed

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic

Metastatic Breast Cancer
NCT00370552

Completed

A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Metastatic Breast Cancer
NCT01161368

Terminated

A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients

Metastatic Breast Cancer
NCT00905281

Completed

Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy

Metastatic Breast Cancer
NCT00911898

Completed

A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers (Monotherapy)

Metastatic Breast Cancer | Her2 Amplified Solid Tumors
NCT02313051

Unknown

Everolimus trIal for Advanced prememopausaL Breast Cancer Patients (MIRACLE)

Metastatic Breast Cancer
NCT01477060

Terminated

Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01613352

Completed

Feasibility of Ambulatory Surgery for Early Breast Cancer

Early Breast Cancer | Ambulatory Surgery | Psychosocial Wellbeing
NCT00172068

Terminated

Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow (MRD-1)

Primary Breast Cancer
NCT06900647

Recruiting

Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer (BOCIS)

Metastatic Breast Cancer | Recurrent Breast Cancer
NCT06860815

Recruiting

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Metastatic Carcinoma in the Liver
NCT06555354

Completed

MicroRNAs and Prognosis in Breast Cancer (BREMIR)

Breast Cancer Female | Metastases Breast
NCT02452333

Completed

Oncoplastic Approach to Excisional Breast Biopsies

Breast Diseases | Neoplasm of Female Breast | Breast Neoplasms Diagnosis | Deformity of Reconstructed Breast
NCT00159458

Terminated

Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer

Recurrent Breast Cancer | Metastastic Breast Cancer
NCT01351597

Unknown

A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer (STORM)

Metastatic Breast Cancer | Recurrent Breast Cancer
NCT07486089

Recruiting

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) (DUAL-NK-BC)

HER2-positive Breast Cancer | Triple-Negative Breast Cancer (TNBC) | Breast Cancer (Locally Advanced or Metastatic)
NCT07086053

Not yet recruiting

Reliability of Myoton in Evaluating Skin Biomechanics in Breast Cancer-Related Lymphedema (MYOLYMPH)

Breast Cancer-Related Lymphedema
NCT06616987

Recruiting

Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer

Breast Cancer Metastatic
NCT04074720

Recruiting

Prospective Breast Cancer Biospecimen Collection

Breast Cancer | Invasive Breast Cancer | Carcinoma in Situ of the Breast
NCT05809752

Active, not recruiting

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

Triple Negative Breast Cancer | HER2-positive Breast Cancer | Leptomeningeal Disease
NCT05610579

Completed

The 24 Hour Effects of Remedial Exercises With and Without Compression Therapy on Breast Cancer-related Lymphedema

Lymphedema, Breast Cancer
NCT02227082

Completed

Olaparib and Radiotherapy in Inoperable Breast Cancer

Locally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast Carcinoma
NCT07357948

Not yet recruiting

Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy (OMICHIR)

Triple Negative Breast Cancer | Non-Metastatic
NCT07289282

Recruiting

Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer (miRNA-NAC)

Breast Cancer | Neoadjuvant Therapy | Invasive Breast Carcinoma | Pathological Response | MicroRNAs
NCT06929325

Not yet recruiting

Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors

HR+/HER2- Advanced/Metastatic Breast Cancer
NCT06908668

Not yet recruiting

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

HER2-Negative Locally Advanced Breast Cancer
NCT06839001

Recruiting

CRYoablation for Small Tumors As Local Treatment - SIX Trial (CRYSTAL - SIX)

Breast Cancer | Breast Neoplasm
NCT06830889

Recruiting

A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy

HER2-positive Breast Cancer
NCT06555068

Recruiting

A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients

Advanced Unresectable or Metastatic Breast Cancer
NCT06470347

Recruiting

A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy

HER-2 Positive Advanced Breast Cancer
NCT06438055

Not yet recruiting

Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

Refractory Breast Cancer
NCT06318507

Recruiting

The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy (IMPACT)

Breast Neoplasms
NCT06291896

Recruiting

A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection

Women's Health: Neoplasm of Breast
NCT06193707

Not yet recruiting

Intelligent Remote Intervention for High-risk Breast Cancer Populations

Ultrasonography | Breast Carcinoma | Breast Neoplasm Female | Health Education
NCT06174259

Recruiting

Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients

Locally Advanced Breast Cancer | Intermittent Fasting
NCT05860465

Recruiting

Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

Locally Advanced or Metastatic Breast Cancer
NCT05525481

Recruiting

Tamoxifen Prediction Study in Patients With ER+ Breast Cancer (PREDICTAM)

ER+ Breast Cancer
NCT05429684

Recruiting

Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

HER2+ Breast Cancer
NCT05403333

Not yet recruiting

Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer
NCT05343117

Recruiting

Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC

Hormone Receptor Positive Advanced Breast Cancer
NCT05295043

Not yet recruiting

Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast Cancer

Advanced HR+ HER2 Negative Breast Carcinoma
NCT05172518

Not yet recruiting

Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer
NCT05167643

Recruiting

H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World Study

Advanced HR+ HER2 Negative Breast Carcinoma
NCT04948983

Recruiting

The Effect of a Patient Decision Aids for Breast Cancer Screening

Breast Cancer | Breast Tumor | Mammary Cancer | Mammary Tumor
NCT04858529

Recruiting

Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study)

Neoadjuvant Therapies for HER2+ Breast Cancer
NCT04605575

Recruiting

Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Breast Diseases | HER2-positive Breast Cancer | Vinorelbine | Pyrotinib
NCT03006614

Recruiting

PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer (PERS)

Breast Cancer | Effects of Chemotherapy | Breast Cancer Model

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations